Weaver C. Barksdale & Associates, Inc. Amgen Inc Transaction History

Weaver C. Barksdale & Associates, Inc.

$111 Million
Q3 2024

A detailed history of Weaver C. Barksdale & Associates, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Weaver C. Barksdale & Associates, Inc. holds 6,956 shares of AMGN stock, worth $1.95 Million. This represents 2.02% of its overall portfolio holdings.

Number of Shares

6,956

Previous 7,215 3.59%

Holding current value

$1.95 Million

Previous $2.25 Million 0.58%

% of portfolio

2.02%

Previous 2.14%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $80,129 - $87,381	-259 Reduced 3.59%	6,956 $2.24 Million
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $31,530 - $38,317	-120 Reduced 1.64%	7,215 $2.25 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $12,099 - $14,605	-45 Reduced 0.61%	7,335 $2.09 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $482,505 - $544,324	-1,887 Reduced 20.36%	7,380 $2.13 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $334,753 - $415,605	1,531 Added 19.79%	9,267 $2.49 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $102,206 - $120,857	-477 Reduced 5.81%	7,736 $1.72 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $89,864 - $109,529	-398 Reduced 4.62%	8,213 $1.99 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $248,726 - $316,036	-1,086 Reduced 11.2%	8,611 $2.26 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $137,593 - $155,180	-613 Reduced 5.95%	9,697 $2.19 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $171,186 - $190,501	742 Added 7.76%	10,310 $2.51 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $27,847 - $30,806	127 Added 1.35%	9,568 $2.31 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $169,445 - $193,915	852 Added 9.92%	9,441 $2.12 Million
Q4 2017 Jan 10, 2018	SELL	$168.79 - $188.59 $14,515 - $16,218	-86 Reduced 0.99%	8,589 $1.49 Million
Q3 2017 Oct 12, 2017	BUY	$167.29 - $191.0 $1.45 Million - $1.66 Million	8,675	8,675 $1.62 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver C. Barksdale & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Weaver C. Barksdale & Associates, Inc. with notifications on news.

Account

Weaver C. Barksdale & Associates, Inc. Amgen Inc Transaction History